These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 21917871)
1. Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus. Vele S; Milman S; Shamoon H; Gabriely I J Clin Endocrinol Metab; 2011 Nov; 96(11):3424-31. PubMed ID: 21917871 [TBL] [Abstract][Full Text] [Related]
2. Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade. Leu J; Cui MH; Shamoon H; Gabriely I J Clin Endocrinol Metab; 2009 Sep; 94(9):3372-80. PubMed ID: 19567512 [TBL] [Abstract][Full Text] [Related]
3. Opioid receptor blockade prevents exercise-associated autonomic failure in humans. Milman S; Leu J; Shamoon H; Vele S; Gabriely I Diabetes; 2012 Jun; 61(6):1609-15. PubMed ID: 22522612 [TBL] [Abstract][Full Text] [Related]
4. The response to hypoglycemia: a role for the opioid system? McCrimmon RJ J Clin Endocrinol Metab; 2011 Nov; 96(11):3357-9. PubMed ID: 22058380 [No Abstract] [Full Text] [Related]
5. Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure. Lontchi-Yimagou E; Aleksic S; Hulkower R; Gospin R; Goyal A; Kuo B; Mitchell WG; You JY; Upadhyay L; Carey M; Sandu OA; Gabriely I; Shamoon H; Hawkins M J Clin Endocrinol Metab; 2020 Nov; 105(11):3416-27. PubMed ID: 32915987 [TBL] [Abstract][Full Text] [Related]
6. Effects of differing antecedent increases of plasma cortisol on counterregulatory responses during subsequent exercise in type 1 diabetes. Bao S; Briscoe VJ; Tate DB; Davis SN Diabetes; 2009 Sep; 58(9):2100-8. PubMed ID: 19509020 [TBL] [Abstract][Full Text] [Related]
7. Limited impact of vigorous exercise on defenses against hypoglycemia: relevance to hypoglycemia-associated autonomic failure. McGregor VP; Greiwe JS; Banarer S; Cryer PE Diabetes; 2002 May; 51(5):1485-92. PubMed ID: 11978646 [TBL] [Abstract][Full Text] [Related]
8. Effects of Intranasal Naloxone on Hypoglycemia-Associated Autonomic Failure (HAAF) in Susceptible Individuals. Aleksic S; Lontchi-Yimagou E; Mitchell W; Boyle C; Matias P; Manavalan A; Goyal A; Carey M; Gabriely I; Hawkins M J Clin Endocrinol Metab; 2024 Jul; ():. PubMed ID: 39026458 [TBL] [Abstract][Full Text] [Related]
9. Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure. Poplawski MM; Mastaitis JW; Mobbs CV Diabetes; 2011 Jan; 60(1):39-46. PubMed ID: 20811039 [TBL] [Abstract][Full Text] [Related]
12. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes. Galassetti P; Tate D; Neill RA; Morrey S; Wasserman DH; Davis SN Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E16-24. PubMed ID: 14998785 [TBL] [Abstract][Full Text] [Related]
13. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Segel SA; Paramore DS; Cryer PE Diabetes; 2002 Mar; 51(3):724-33. PubMed ID: 11872673 [TBL] [Abstract][Full Text] [Related]
14. Magnitude of exercise-induced β-endorphin response is associated with subsequent development of altered hypoglycemia counterregulation. Milman S; Leu J; Shamoon H; Vele S; Gabriely I J Clin Endocrinol Metab; 2012 Feb; 97(2):623-31. PubMed ID: 22170706 [TBL] [Abstract][Full Text] [Related]
15. Partial blockade of nicotinic acetylcholine receptors improves the counterregulatory response to hypoglycemia in recurrently hypoglycemic rats. LaGamma EF; Kirtok N; Chan O; Nankova BB Am J Physiol Endocrinol Metab; 2014 Oct; 307(7):E580-8. PubMed ID: 25117409 [TBL] [Abstract][Full Text] [Related]
16. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes. Bernroider E; Brehm A; Krssak M; Anderwald C; Trajanoski Z; Cline G; Shulman GI; Roden M J Clin Endocrinol Metab; 2005 Oct; 90(10):5559-65. PubMed ID: 15998784 [TBL] [Abstract][Full Text] [Related]
17. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Fanelli CG; Paramore DS; Hershey T; Terkamp C; Ovalle F; Craft S; Cryer PE Diabetes; 1998 Dec; 47(12):1920-7. PubMed ID: 9836525 [TBL] [Abstract][Full Text] [Related]
18. Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes. Aftab Guy D; Sandoval D; Richardson MA; Tate D; Davis SN Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E258-65. PubMed ID: 15784645 [TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia-associated autonomic failure in healthy humans: comparison of two vs three periods of hypoglycemia on hypoglycemia-induced counterregulatory and symptom response 5 days later. Moheet A; Kumar A; Eberly LE; Kim J; Roberts R; Seaquist ER J Clin Endocrinol Metab; 2014 Feb; 99(2):664-70. PubMed ID: 24423306 [TBL] [Abstract][Full Text] [Related]
20. Repetitive hypoglycemia reduces activation of glucose-responsive neurons in C1 and C3 medullary brain regions to subsequent hypoglycemia. Kakall ZM; Kavurma MM; Cohen EM; Howe PR; Nedoboy PE; Pilowsky PM Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E388-E398. PubMed ID: 31013147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]